These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25659145)

  • 21. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors.
    Su X; Pradaux-Caggiano F; Thomas MP; Szeto MW; Halem HA; Culler MD; Vicker N; Potter BV
    ChemMedChem; 2010 Jul; 5(7):1026-44. PubMed ID: 20486152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, anti-diabetic evaluation and molecular docking studies of 4-(1-aryl-1H-1, 2, 3-triazol-4-yl)-1,4-dihydropyridine derivatives as novel 11-β hydroxysteroid dehydrogenase-1 (11β-HSD1) inhibitors.
    Praveenkumar E; Gurrapu N; Kumar Kolluri P; Yerragunta V; Reddy Kunduru B; Subhashini NJP
    Bioorg Chem; 2019 Sep; 90():103056. PubMed ID: 31276952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 2-(Adamantan-1-ylamino)Thiazol-4(5
    Studzińska R; Kupczyk D; Płaziński W; Baumgart S; Bilski R; Paprocka R; Kołodziejska R
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
    Roche D; Carniato D; Leriche C; Lepifre F; Christmann-Franck S; Graedler U; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E
    Bioorg Med Chem Lett; 2009 May; 19(10):2674-8. PubMed ID: 19395260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel 7-membered cyclic amide derivatives that inhibit 11beta-hydroxysteroid dehydrogenase type 1.
    Udagawa S; Sakami S; Takemura T; Sato M; Arai T; Nitta A; Aoki T; Kawai K; Iwamura T; Okazaki S; Takahashi T; Kaino M
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1617-21. PubMed ID: 23414800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
    Su X; Vicker N; Thomas MP; Pradaux-Caggiano F; Halem H; Culler MD; Potter BV
    ChemMedChem; 2011 Aug; 6(8):1439-51. PubMed ID: 21608132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
    Shao LD; Bao Y; Shen Y; Su J; Leng Y; Zhao QS
    Eur J Med Chem; 2017 Jul; 135():324-338. PubMed ID: 28458137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
    Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes.
    Hamilton BS; Himmelsbach F; Nar H; Schuler-Metz A; Krosky P; Guo J; Guo R; Meng S; Zhao Y; Lala DS; Zhuang L; Claremon DA; McGeehan GM
    Eur J Pharmacol; 2015 Jan; 746():50-5. PubMed ID: 25445047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model.
    Julian LD; Wang Z; Bostick T; Caille S; Choi R; DeGraffenreid M; Di Y; He X; Hungate RW; Jaen JC; Liu J; Monshouwer M; McMinn D; Rew Y; Sudom A; Sun D; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP
    J Med Chem; 2008 Jul; 51(13):3953-60. PubMed ID: 18553955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and application of a scintillation proximity assay (SPA) for identification of selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
    Mundt S; Solly K; Thieringer R; Hermanowski-Vosatka A
    Assay Drug Dev Technol; 2005 Aug; 3(4):367-75. PubMed ID: 16180991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and biological evaluation of novel selective peptide inhibitors of 11β-hydroxysteroid dehydrogenase 1.
    Boudon S; Heidl M; Vuorinen A; Wandeler E; Campiche R; Odermatt A; Jackson E
    Bioorg Med Chem; 2018 Oct; 26(18):5128-5139. PubMed ID: 30245006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 11β-HSD1 inhibitors: C-1 versus C-2 substitution and effect of the introduction of an oxygen atom in the adamantane scaffold.
    Leiva R; Seira C; McBride A; Binnie M; Luque FJ; Bidon-Chanal A; Webster SP; Vázquez S
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4250-3. PubMed ID: 26306982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid action.
    Nashev LG; Vuorinen A; Praxmarer L; Chantong B; Cereghetti D; Winiger R; Schuster D; Odermatt A
    PLoS One; 2012; 7(10):e46958. PubMed ID: 23056542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening.
    Schuster D; Maurer EM; Laggner C; Nashev LG; Wilckens T; Langer T; Odermatt A
    J Med Chem; 2006 Jun; 49(12):3454-66. PubMed ID: 16759088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1).
    Sun D; Wang Z; Di Y; Jaen JC; Labelle M; Ma J; Miao S; Sudom A; Tang L; Tomooka CS; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3513-6. PubMed ID: 18511278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
    Su X; Halem HA; Thomas MP; Moutrille C; Culler MD; Vicker N; Potter BV
    Bioorg Med Chem; 2012 Nov; 20(21):6394-402. PubMed ID: 23040895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of flavonoids and isoflavonoids to inhibit rat and human 11β-hydroxysteroid dehydrogenase 1 and 2.
    Zhu Q; Ge F; Dong Y; Sun W; Wang Z; Shan Y; Chen R; Sun J; Ge RS
    Steroids; 2018 Apr; 132():25-32. PubMed ID: 29425740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of the N-methyl Derivatives of 2-Aminothiazol-4(5H)-one and Their Interactions with 11βHSD1-Molecular Modeling and in Vitro Studies.
    Studzińska R; Kołodziejska R; Płaziński W; Kupczyk D; Kosmalski T; Jasieniecka K; Modzelewska-Banachiewicz B
    Chem Biodivers; 2019 Jun; 16(6):e1900065. PubMed ID: 31012543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor.
    Ye XY; Chen SY; Wu S; Yoon DS; Wang H; Hong Z; O'Connor SP; Li J; Li JJ; Kennedy LJ; Walker SJ; Nayeem A; Sheriff S; Camac DM; Ramamurthy V; Morin PE; Zebo R; Taylor JR; Morgan NN; Ponticiello RP; Harrity T; Apedo A; Golla R; Seethala R; Wang M; Harper TW; Sleczka BG; He B; Kirby M; Leahy DK; Li J; Hanson RL; Guo Z; Li YX; DiMarco JD; Scaringe R; Maxwell B; Moulin F; Barrish JC; Gordon DA; Robl JA
    J Med Chem; 2017 Jun; 60(12):4932-4948. PubMed ID: 28537398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.